Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza neuraminidase is a surface glycoprotein enzyme found on the influenza virus. It plays a critical role in the viral life cycle by enabling the release of newly formed virus particles from infected host cells, thereby facilitating the spread of infection within the host. It acts as an exosialidase (EC 3.2.1.18), cleaving α-ketosidic linkages between sialic acid and adjacent sugar residues on glycoproteins and glycolipids at cell surfaces or viral proteins. Neuraminidase is an established target for antiviral drugs like oseltamivir and zanamivir. Resistance can develop through mutations such as H274Y substitution in NA; ongoing surveillance for resistance mutations is essential for effective treatment strategies.
Competitive inhibition of neuraminidase enzyme activity, preventing viral release from infected cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Neuraminidase Protein.